McKesson to acquire 70% stake in Core Ventures for $2.5bn to expand oncology platform

In a strategic move to bolster its presence in community-based oncology care, McKesson Corporation (NYSE: MCK) has signed a definitive agreement to acquire a controlling ... Read More